COSMOS Pharmaceutical Corporation (TYO:3349)

COSMOS Pharmaceutical Ratios and Metrics

Market cap in millions JPY. Fiscal year is June - May.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov 20, 2025	May 31, 2025	May 31, 2024	May 31, 2023	May 31, 2022	May 31, 2021
Market Capitalization	602,514	700,001	502,890	525,081	483,107	603,094
Market Cap Growth	4.25%	39.20%	-4.23%	8.69%	-19.89%	-1.55%
Enterprise Value	594,522	705,765	495,143	507,058	456,292	562,389
Last Close Price	7602.00	8832.00	6290.18	6516.74	5952.64	7389.88
PE Ratio	19.43	22.60	20.57	22.07	20.86	22.21
Forward PE	18.30	21.94	19.07	21.97	19.33	24.17
PS Ratio	0.59	0.69	0.52	0.63	0.64	0.83
PB Ratio	2.29	2.72	2.17	2.49	2.54	3.54
P/TBV Ratio	2.30	2.72	2.18	2.49	2.54	3.54
P/FCF Ratio	-	-	-	67.33	-	333.02
P/OCF Ratio	-	13.34	9.11	9.65	15.01	21.64
PEG Ratio	3.68	2.26	2.90	5.05	2.14	2.32
EV/Sales Ratio	0.58	0.70	0.51	0.61	0.60	0.77
EV/EBITDA Ratio	9.46	11.27	9.63	10.68	10.16	11.98
EV/EBIT Ratio	14.86	17.47	15.72	16.83	15.31	16.97
EV/FCF Ratio	-	-	-	65.02	-	310.54
Debt / Equity Ratio	0.16	0.19	0.15	0.09	0.05	0.06
Debt / EBITDA Ratio	0.66	0.80	0.66	0.38	0.21	0.22
Debt / FCF Ratio	-	-	-	2.33	-	5.77
Asset Turnover	2.03	2.02	2.15	2.11	2.15	2.20
Inventory Turnover	9.16	8.94	9.49	9.16	9.52	10.19
Quick Ratio	0.23	0.31	0.30	0.29	0.28	0.39
Current Ratio	0.74	0.75	0.72	0.71	0.71	0.78
Return on Equity (ROE)	12.41%	12.67%	11.05%	11.85%	12.83%	17.17%
Return on Assets (ROA)	4.96%	5.04%	4.39%	4.80%	5.29%	6.26%
Return on Capital (ROIC)	8.80%	8.82%	7.96%	8.77%	9.78%	12.23%
Return on Capital Employed (ROCE)	13.00%	13.30%	12.00%	13.20%	14.80%	18.20%
Earnings Yield	5.15%	4.42%	4.86%	4.53%	4.79%	4.50%
FCF Yield	-	-0.12%	-0.13%	1.49%	-2.34%	0.30%
Dividend Yield	0.99%	0.79%	0.95%	0.77%	0.67%	0.47%
Payout Ratio	-	16.01%	19.05%	13.72%	14.11%	8.38%
Buyback Yield / Dilution	-0.00%	-0.02%	-0.05%	0.00%	0.00%	0.00%
Total Shareholder Return	0.98%	0.77%	0.90%	0.77%	0.67%	0.47%

Updated Aug 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.